CN111777680B - Separation and purification process for improving stability of recombinant collagen solution - Google Patents
Separation and purification process for improving stability of recombinant collagen solution Download PDFInfo
- Publication number
- CN111777680B CN111777680B CN202010609943.XA CN202010609943A CN111777680B CN 111777680 B CN111777680 B CN 111777680B CN 202010609943 A CN202010609943 A CN 202010609943A CN 111777680 B CN111777680 B CN 111777680B
- Authority
- CN
- China
- Prior art keywords
- separation
- recombinant collagen
- purification process
- membrane
- pichia pastoris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 36
- 108010035532 Collagen Proteins 0.000 title claims abstract description 36
- 229920001436 collagen Polymers 0.000 title claims abstract description 36
- 238000000746 purification Methods 0.000 title claims abstract description 17
- 238000000926 separation method Methods 0.000 title claims abstract description 17
- 239000012528 membrane Substances 0.000 claims abstract description 39
- 239000006228 supernatant Substances 0.000 claims abstract description 22
- 238000001728 nano-filtration Methods 0.000 claims abstract description 15
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 14
- 239000000919 ceramic Substances 0.000 claims abstract description 14
- 238000000855 fermentation Methods 0.000 claims abstract description 12
- 230000004151 fermentation Effects 0.000 claims abstract description 12
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 239000002253 acid Substances 0.000 claims abstract description 10
- 239000012535 impurity Substances 0.000 claims abstract description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 16
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 5
- 241000235648 Pichia Species 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 6
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 3
- 239000000047 product Substances 0.000 abstract description 3
- 239000000243 solution Substances 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000008213 purified water Substances 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a separation and purification process for improving the stability of a recombinant collagen solution. The process comprises the steps of centrifugally separating pichia pastoris fermentation liquid, collecting supernatant, adding acid to adjust the pH to 3-4, filtering by a ceramic membrane to remove impurities, concentrating by a nanofiltration membrane to deacidify until the pH is 5.5+/-0.5, and obtaining the high-purity recombinant collagen solution. The method is simple to operate, the purity of the recombinant collagen obtained by separation and purification can reach 97.16%, the stability of the recombinant collagen in aqueous solution and the purity of the product are obviously improved, and the method is suitable for large-scale production by using membrane filtering equipment in the separation and purification process of the recombinant collagen.
Description
Technical Field
The invention belongs to the technical field of separation and purification of biological products, and relates to a separation and purification process for improving stability of a recombinant collagen solution.
Background
Collagen is a family of proteins with the most abundant content in animals, and is widely used as a natural biological material in the fields of foods, cosmetics and medical treatment. However, most of the collagen is derived from animal skin, bones and other tissues of animals such as pigs, cattle, fish and the like, and is mainly obtained by physical and chemical treatment such as acid, alkali, heating and the like, the raw material components are complex, the batch diversity is large, the hidden danger of viruses exists, a large amount of acid-base wastewater is generated in the production process, the environmental pollution is serious, the immunogenicity needs to be increased and removed due to the heterology of the animals and the human body, and the further application of the collagen in medicine is limited.
Along with the development of modern DNA recombination technology, various host cells are selected as genetic engineering bacteria for constructing and expressing collagen, so that the defects of animal-derived collagen are overcome. Chinese patent 201110327865.5 constructs a Pichia pastoris genetically engineered strain of recombinant collagen, the strain is fermented and cultured to obtain the recombinant collagen, the fermentation period is 136 hours, and the protein expression quantity is 16g/L. The fermentation liquor is collected after centrifugation, and the supernatant is filtered by a filter membrane and separated and purified by Sephadex G100 gel column chromatography, so that the method has higher cost in large-scale production. Patent application CN104561201a utilizes ultrafiltration and nanofiltration membrane equipment to produce human-like collagen. The membrane filtration process is simple and is suitable for industrial mass production. However, in the process of membrane filtration, the recombinant collagen is separated from the environment of the fermentation broth, circulates at a high speed in the membrane equipment, is difficult to completely maintain the hydrolytic stability, and partial protein is degraded, so that the activity of the product is reduced.
Disclosure of Invention
The invention aims to provide a separation and purification process for improving the stability of a recombinant collagen solution, which is beneficial to mass production by using membrane filtration equipment by reducing the pH value of the recombinant collagen solution and changing the pH environment of the recombinant collagen solution to cause the change of charges and covalent bonds of protein molecules.
The technical scheme for realizing the purpose of the invention is as follows:
a separation and purification process for improving stability of recombinant collagen solution comprises the following specific steps: and (3) centrifugally separating the pichia pastoris fermentation broth, collecting supernatant, adding acid to adjust the pH to 3-4, filtering by a ceramic membrane to remove impurities, concentrating by a nanofiltration membrane, and deacidifying until the pH is 5.5+/-0.5 to obtain the recombinant collagen solution.
The Pichia pastoris is Pichia pastoris, and is preserved in China general microbiological culture collection center (CGMCC) with the preservation number of CGMCC No.5021 in the year 2011, 6 and 29, and fully disclosed in China patent 201110327865.5.
Preferably, the pH is adjusted to 3.2 to 3.7, more preferably 3.5, by adding an acid.
Preferably, the acid is phosphoric acid or acetic acid, preferably phosphoric acid.
The ceramic membrane disclosed by the invention adopts a ceramic membrane conventionally used in the field, and the pore diameter of the membrane core of the ceramic membrane is 20-200 nm, preferably 100nm.
Preferably, the nanofiltration membrane adopts a nanofiltration membrane which is conventionally used in the field, and the pore diameter of the membrane core of the nanofiltration membrane is 3 KD-7 KD, preferably 5KD.
Compared with the prior art, the invention has the following remarkable effects: the invention discovers that the stability of the recombinant collagen is inversely related to the pH for the first time. In the separation and purification process of the recombinant collagen, the pH of the centrifugal supernatant is regulated to 3-4 by adding acid, the pH environment of the recombinant collagen solution is changed, and the change of the electric charge and covalent bonds of protein molecules is caused, so that the recombinant collagen is more stable, the purity of the recombinant collagen is improved, and the large-scale production by using membrane filtering equipment is facilitated.
Detailed Description
In the specific embodiment of the invention, the adopted strain is Pichia pastoris for expressing recombinant collagen, the preservation number is CGMCC NO.5021, the preservation date is 2011, the month is 29, and the preservation unit is China general microbiological culture Collection center of China Committee for culture Collection of microorganisms.
The invention will be further described in detail with reference to specific examples.
Example 1
(1) Centrifuging Pichia pastoris fermentation broth, and collecting supernatant;
(2) Adding phosphoric acid into the supernatant to adjust the pH to 4.0;
(3) Filtering 200L supernatant by washing with 100nm ceramic membrane, and collecting dialysate 300L;
(4) Concentrating and deacidifying the dialysate by adopting a nanofiltration membrane core of 5KD, adding purified water for concentration each time, sampling and measuring pH until the pH is 5.5 to obtain high-concentration concentrated solution 21L, and detecting the purity of the recombinant collagen to be 94.52%.
Example 2
(1) Centrifuging Pichia pastoris fermentation broth, and collecting supernatant;
(2) Adding phosphoric acid into the supernatant to adjust the pH to 3.7;
(3) Filtering 200L supernatant by washing with 100nm ceramic membrane, and collecting dialysate 300L;
(4) Concentrating and deacidifying the dialysate by adopting a nanofiltration membrane core of 5KD, adding purified water for concentration each time, sampling and measuring pH until the pH is 5.5, obtaining high-concentration concentrated solution 20L, and detecting the purity of the recombinant collagen to be 95.83%.
Example 3
(1) Centrifuging Pichia pastoris fermentation broth, and collecting supernatant;
(2) Adding phosphoric acid into the supernatant to adjust the pH to 3.5;
(3) Filtering 200L supernatant by washing with 100nm ceramic membrane, and collecting dialysate 300L;
(4) Concentrating and deacidifying the dialysate by adopting a nanofiltration membrane core of 5KD, adding purified water for concentration each time, sampling and measuring pH until the pH is 5.5, obtaining high-concentration concentrated solution of 20.5L, and detecting the purity of the recombinant collagen to be 97.16%.
Example 4
(1) Centrifuging Pichia pastoris fermentation broth, and collecting supernatant;
(2) Adding phosphoric acid into the supernatant to adjust the pH to 3.2;
(3) Filtering 200L supernatant by washing with 100nm ceramic membrane, and collecting dialysate 300L;
(4) Concentrating and deacidifying the dialysate by adopting a nanofiltration membrane core of 5KD, adding purified water for concentration each time, sampling and measuring pH until the pH is 5.5 to obtain a high-concentration concentrated solution 22L, and detecting the purity of the recombinant collagen to be 95.20%.
Example 5
(1) Centrifuging Pichia pastoris fermentation broth, and collecting supernatant;
(2) Adding phosphoric acid into the supernatant to adjust the pH to 3.0;
(3) Filtering 200L supernatant by washing with 100nm ceramic membrane, and collecting dialysate 300L;
(4) Concentrating and deacidifying the dialysate by adopting a nanofiltration membrane core of 5KD, adding purified water for concentration each time, sampling and measuring pH until the pH is 5.5, obtaining high-concentration concentrated solution 20L, and detecting the purity of the recombinant collagen to be 94.81%.
Comparative example
(1) The Pichia pastoris fermentation broth is centrifuged and the supernatant is collected.
(2) Filtering 200L supernatant by washing with 100nm ceramic membrane, and collecting dialysate 300L;
(3) Concentrating and deacidifying the dialysate by adopting a nanofiltration membrane core of 5KD, adding purified water for concentration each time, sampling and measuring pH until the pH is 5.5 to obtain high-concentration concentrated solution 21L, and detecting the purity of the recombinant collagen to be 92.33%.
Claims (7)
1. A separation and purification process for improving stability of recombinant collagen solution is characterized by comprising the following specific steps: centrifugally separating a pichia pastoris fermentation broth, collecting a supernatant, adding acid to adjust the pH to 3-4, filtering by a ceramic membrane to remove impurities, concentrating and deacidifying by a nanofiltration membrane until the pH is 5.5+/-0.5 to obtain a recombinant collagen solution, wherein pichia pastoris is pichia pastorisPichia pastorisThe preservation number is CGMCC No.5021, and the acid is phosphoric acid or acetic acid.
2. The separation and purification process according to claim 1, wherein the pH is adjusted to 3.2 to 3.7 by adding an acid.
3. The separation and purification process according to claim 1, wherein the pH is adjusted to 3.5 by adding an acid.
4. The separation and purification process according to claim 1, wherein the ceramic membrane has a membrane core pore size of 20-200 nm.
5. The separation and purification process according to claim 1, wherein the ceramic membrane has a membrane core pore size of 100nm.
6. The separation and purification process according to claim 1, wherein the nanofiltration membrane has a membrane core pore size of 3kd to 7kd.
7. The separation and purification process according to claim 1, wherein the nanofiltration membrane has a membrane core pore size of 5KD.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010609943.XA CN111777680B (en) | 2020-06-30 | 2020-06-30 | Separation and purification process for improving stability of recombinant collagen solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010609943.XA CN111777680B (en) | 2020-06-30 | 2020-06-30 | Separation and purification process for improving stability of recombinant collagen solution |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111777680A CN111777680A (en) | 2020-10-16 |
CN111777680B true CN111777680B (en) | 2023-11-03 |
Family
ID=72761023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010609943.XA Active CN111777680B (en) | 2020-06-30 | 2020-06-30 | Separation and purification process for improving stability of recombinant collagen solution |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111777680B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112625120B (en) * | 2020-12-25 | 2023-07-04 | 浙江诸暨聚源生物技术有限公司 | Process for continuous large-scale production of recombinant collagen |
CN114470333B (en) * | 2022-03-09 | 2023-05-23 | 哈尔滨敷尔佳科技股份有限公司 | Preparation method of crosslinked recombinant collagen gel |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007124901A (en) * | 2005-11-01 | 2007-05-24 | Teikyo Univ | Method for extracting collagen |
CN102146426A (en) * | 2010-12-23 | 2011-08-10 | 陕西九州生物医药科技园发展有限公司 | Method for producing recombinant human-like collagen by expression by Pichia pastoris |
CN104561201A (en) * | 2014-12-29 | 2015-04-29 | 山东鲁抗医药股份有限公司 | Method for extracting recombinant human-like collagen with membrane filter method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106191181B (en) * | 2016-07-22 | 2019-12-13 | 江苏江山聚源生物技术有限公司 | Fermentation process for expressing recombinant protein by pichia pastoris |
-
2020
- 2020-06-30 CN CN202010609943.XA patent/CN111777680B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007124901A (en) * | 2005-11-01 | 2007-05-24 | Teikyo Univ | Method for extracting collagen |
CN102146426A (en) * | 2010-12-23 | 2011-08-10 | 陕西九州生物医药科技园发展有限公司 | Method for producing recombinant human-like collagen by expression by Pichia pastoris |
CN104561201A (en) * | 2014-12-29 | 2015-04-29 | 山东鲁抗医药股份有限公司 | Method for extracting recombinant human-like collagen with membrane filter method |
Non-Patent Citations (2)
Title |
---|
Warner LR等.Expression, purification, and refolding of recombinant collagen alpha1(XI) amino terminal domain splice variants.《Protein Expr Purif》.2006,第52卷(第2期),403-9. * |
侯增淼等.重组人源性胶原蛋白的制备及表征.《生物工程学报》.2019,第35卷(第2期),319-326. * |
Also Published As
Publication number | Publication date |
---|---|
CN111777680A (en) | 2020-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100567500C (en) | A kind of method of from produce the Polysialic acid escherichia coli fermented broth, extracting Polysialic acid | |
CN111777680B (en) | Separation and purification process for improving stability of recombinant collagen solution | |
CN109251954B (en) | Production method of sea cucumber polypeptide | |
CN101619308B (en) | Preparation method for extracting lysozyme from egg white | |
CN112724242B (en) | Method for producing recombinant human-like collagen and host cell protein by using pichia pastoris | |
CN109988739A (en) | The method that one-step method efficiently prepares small molecule chondroitin sulfate and micromolecule hyaluronic acid | |
CN109136299B (en) | Method for preparing, extracting and purifying threonine | |
CN113005161A (en) | Preparation method of polysialic acid and polysialic acid product | |
CN104387459A (en) | Industrial separation and purification method of bacterial source antibacterial peptide | |
CN109601437B (en) | Method for stress secretion and collection of loach mucus | |
CN111574639A (en) | Method for separating and purifying nitraria tangutorum bobr polysaccharide | |
CN1300311C (en) | Preparation method of chitin incision enzyme | |
CN116509764A (en) | Yeast fermentation product filtrate containing recombinant type 17 human collagen | |
CN106518700A (en) | Glutamicacid membrane method production process | |
CN102604917A (en) | Preparation method of high-purity nattokinase | |
CN112625120B (en) | Process for continuous large-scale production of recombinant collagen | |
CN114480546A (en) | Method for improving yield of low-molecular-weight soybean peptide | |
CN220149478U (en) | Separation and purification device for improving stability of recombinant collagen repair solution | |
CN1544645A (en) | Double-enzyme method for preparing chondroitin sulfate | |
CN113563488A (en) | Preparation method of pharmaceutical-grade micromolecular marine organism polysaccharide | |
CN108220351B (en) | Method for preparing L-arginine-alpha-ketoglutaric acid by biological enzyme method | |
CN101704887A (en) | Matrix protein in nacre based on secretions of mantle of pinctada and preparation method thereof | |
CN107090020B (en) | Edible fungus agglutinin and application thereof in inhibiting growth of phaeocystis | |
CN109370996A (en) | A kind of catalase sublimate method of purification | |
CN110724721B (en) | Preparation method of antifungal peptide of meiyu processing byproduct |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |